Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-20-003466
Filing Date
2020-06-09
Accepted
2020-06-10 09:29:27
Documents
4
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2241825zpre14a.htm PRE 14A 312062
2 G957926.JPG g957926.jpg GRAPHIC 37583
3 G534329.JPG g534329.jpg GRAPHIC 11540
4 G213072BGI001.GIF g213072bgi001.gif GRAPHIC 159632
  Complete submission text file 0001047469-20-003466.txt   600978
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36714 | Film No.: 20953655
SIC: 2834 Pharmaceutical Preparations